Large-scale testing (Phase 3)Ended earlyNCT03467958What this trial is testingAn Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Celgene 854
Large-scale testing (Phase 3)Study completedNCT03945019What this trial is testingCT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)Who this might be right forCrohn's Disease Celltrion 396
Not applicableEnded earlyNCT00936585What this trial is testingNIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's DiseaseWho this might be right forColitisCrohn's DiseaseInflammatory Bowel Disease National Institutes of Health Clinical Center (CC) 2
Testing effectiveness (Phase 2)Looking for participantsNCT06233461What this trial is testingA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Takeda 268
Testing effectiveness (Phase 2)Looking for participantsNCT07078994What this trial is testingClinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's DiseaseWho this might be right forCrohn's Disease (CD) Biocad 204
Early research (Phase 1)Study completedNCT04254783What this trial is testingEvaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseWho this might be right forUlcerative Colitis (UC)Crohn's Disease AbbVie 20
Testing effectiveness (Phase 2)Study completedNCT02389790What this trial is testingExtension Study of MT-1303 in Subjects With Crohn's DiseaseWho this might be right forCrohn's Disease Tanabe Pharma Corporation 46
Large-scale testing (Phase 3)Ended earlyNCT04173273What this trial is testingA Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Pfizer 379
Testing effectiveness (Phase 2)Study completedNCT03854305What this trial is testingPhase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Provention Bio, Inc. 93
Large-scale testing (Phase 3)Study completedNCT00078611What this trial is testingA Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Biogen 462
Large-scale testing (Phase 3)Ended earlyNCT03759288What this trial is testingAn Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's DiseaseIBD AstraZeneca 89
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07753850What this trial is testingSL-325 in Crohn's Disease PatientsWho this might be right forCrohn's Disease Shattuck Labs, Inc. 232
Early research (Phase 1)WithdrawnNCT05028946What this trial is testingOral Foralumab in Participants With Moderate to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Tiziana Life Sciences LTD
Testing effectiveness (Phase 2)Study completedNCT00737932What this trial is testingLaquinimod Phase IIa Study in Active Crohn's DiseaseWho this might be right forCrohn's Disease Teva Branded Pharmaceutical Products R&D, Inc. 180
Large-scale testing (Phase 3)Study completedNCT02611817What this trial is testingEfficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)Who this might be right forCrohn's Disease Takeda 644
Large-scale testing (Phase 3)Looking for participantsNCT07577843What this trial is testingJNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Janssen Research & Development, LLC 460
Large-scale testing (Phase 3)Study completedNCT00552344What this trial is testingEvaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's DiseaseWho this might be right forCrohn Disease UCB BIOSCIENCES GmbH 403
Large-scale testing (Phase 3)Looking for participantsNCT04779320What this trial is testingVedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)Who this might be right forCrohn's Disease (CD) Takeda 120
Large-scale testing (Phase 3)Looking for participantsNCT06430801What this trial is testingEvaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)Who this might be right forCrohn's Disease Merck Sharp & Dohme LLC 1,200
Large-scale testing (Phase 3)Study completedNCT01369355What this trial is testingEvaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)Who this might be right forCrohn's DiseaseColitisIBD+1 more Janssen Research & Development, LLC 1,282